Alginic acid Completed Phase 2 Trials for Cystic Fibrosis (CF) / Burkholderia Infection Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02453789A Study of OligoG in Cystic Fibrosis Subjects With Burkholderia Spp. Infection
NCT02157922A Phase IIb Study of OligoG in Subjects With Cystic Fibrosis